Stocktoria

PULSE BIOSCIENCES, INC. PLSE

Nasdaq · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2016-05-18 · LEI

PULSE BIOSCIENCES, INC. statistics & valuation

P / B24.4×
Net margin-20794.6%
FCF margin-15553.4%
Return on capital-88.8%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-4489.40% -8357.90% -20794.60% 2016201720182019202020212022202320242025
Gross margin (%)
2016201720182019202020212022202320242025
Operating margin (%)
-4443.90% -8293.90% -21982.60% 2016201720182019202020212022202320242025
Return on equity (%)
-37.60% -55.60% -56.60% -152.80% -217.70% -143.50% -95.20% -46.70% -90.20% 2016201720182019202020212022202320242025
Shares outstanding
13.3M 16.8M 20.6M 20.8M 25.6M 55.1M 37.2M 55.1M 65.9M 67.8M 2016201720182019202020212022202320242025
Net debt ($)
2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
-36.20% -51.30% -53.10% -112.10% -120.70% -107.60% -75.10% -71.40% -40.50% -77.00% 2016201720182019202020212022202320242025
Free cash flow margin (%)
-3845.80% -6773.40% -15553.40% 2016201720182019202020212022202320242025
Debt / equity (×)
2016201720182019202020212022202320242025
EPS ($)
2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating margin-21982.6%-8293.9%-4443.9%
Net margin-20794.6%-8357.9%-4489.4%
FCF margin-15553.4%-6773.4%-3845.8%
Return on assets-77.0%-40.5%-71.4%-75.1%-107.6%-120.7%-112.1%-53.1%-51.3%-36.2%
Return on equity-90.2%-46.7%-95.2%2602.5%-143.5%-217.7%-152.8%-56.6%-55.6%-37.6%
Current ratio10.5311.886.7610.396.762.955.9219.4217.3916.40

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.